Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cara Therapeutics Inc (CARA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7851
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes KORSUVA injection, which is in Phase III clinical trial for the treatment of patients with chronic kidney disease associated pruritus undergoing hemodialysis, and dialysis of patients suffering from uremic pruritus. Cara Therapeutics develops molecules at novel analgesic and anti-inflammatory targets using proprietary drug screening technology. The company serves pharmaceutical and healthcare sectors. Cara Therapeutics is headquartered in Stamford, Connecticut, the US.

Cara Therapeutics Inc (CARA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cara Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cara Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cara Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cara Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cara Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cara Therapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Cara Therapeutics Raises USD98.3 Million in Public Offering of Shares 10
Cara Therapeutics Raises USD92 Million in Public Offering of Shares 12
Cara Therapeutics Raises USD80.5 Million in Public Offering of Shares 14
Cara Therapeutics Raises USD0.1 Million in Private Placement of Shares 16
Cara Therapeutics Completes IPO For US$63.3 Million 17
Cara Therapeutics Inc – Key Competitors 18
Cara Therapeutics Inc – Key Employees 19
Cara Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2018: Cara Therapeutics Reports Second Quarter 2018 Financial Results 21
May 09, 2018: Cara Therapeutics Reports First Quarter 2018 Financial Results 23
Mar 15, 2018: Cara Therapeutics Announces Fourth Quarter And Full Year 2017 Financial Results 25
Nov 02, 2017: Cara Therapeutics Reports Third Quarter 2017 Financial Results 28
Aug 03, 2017: Cara Therapeutics Reports Second Quarter 2017 Financial Results 30
May 04, 2017: Cara Therapeutics Reports First Quarter 2017 Financial Results 32
Mar 09, 2017: Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Cara Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Cara Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cara Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cara Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cara Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cara Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Cara Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cara Therapeutics Raises USD98.3 Million in Public Offering of Shares 10
Cara Therapeutics Raises USD92 Million in Public Offering of Shares 12
Cara Therapeutics Raises USD80.5 Million in Public Offering of Shares 14
Cara Therapeutics Raises USD0.1 Million in Private Placement of Shares 16
Cara Therapeutics Completes IPO For US$63.3 Million 17
Cara Therapeutics Inc, Key Competitors 18
Cara Therapeutics Inc, Key Employees 19

List of Figures
Cara Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cara Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cara Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cara Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cara Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cara Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cara Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cara Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Monteloeder S.L.:戦略・SWOT・企業財務分析
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PACCAR Inc.:戦略・SWOT・企業財務分析
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Northern Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Northern Biologics Inc (Northern Biologics) is a biotechnology company, which develops antibody-based- immuno-oncology medicines for treating cancers. Its pipeline product portfolio includes MSC-1, a first-in-class humanized antibody targeting leukemia inhibitory factor (LIF), a major immuno …
  • Eurocommercial Properties NV:企業の戦略・SWOT・財務分析
    Eurocommercial Properties NV - Strategy, SWOT and Corporate Finance Report Summary Eurocommercial Properties NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, p …
  • Anixter International Inc (AXE):電力:M&Aディール及び事業提携情報
    Summary Anixter International Inc. (Anixter), formerly Itel Corporation, is a distributor of network and security solutions, electrical and electronic solutions and utility power solutions. The company distributes communications, and electrical wire and cable products, fasteners and C Class inventor …
  • IACInterActiveCorp (IAC):企業の財務・戦略的SWOT分析
    IACInterActiveCorp (IAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Gerdau S.A.:企業の戦略・SWOT・財務情報
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Conversant Intellectual Property Management Inc.:企業のM&A・事業提携・投資動向
    Conversant Intellectual Property Management Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Conversant Intellectual Property Management Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HCR ManorCare Inc:企業の戦略・SWOT・財務情報
    HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report Summary HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Polenergia SA (PEP):企業の財務・戦略的SWOT分析
    Polenergia SA (PEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Danubius Hotel And Spa Private Company Limited:企業の戦略・SWOT・財務分析
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Wintrust Financial Corporation:企業のM&A・事業提携・投資動向
    Wintrust Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wintrust Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • INTRUST Financial Corporation:企業の戦略・SWOT・財務情報
    INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NV Nederlandse Gasunie:企業の戦略的SWOT分析
    NV Nederlandse Gasunie - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆